CIK 0001124105
- Accelerated filer
- Smaller reporting company
GYRE THERAPEUTICS, INC.
Sign in to watch- Ticker
- GYRE
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 562020050
- Phone
- +1 858-284-0115
- Business address
- 12730 HIGH BLUFF DRIVE, SUITE 250, SAN DIEGO, CA, 92130
- Former names
- CATALYST BIOSCIENCES, INC., TARGACEPT INC
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Grant or award Director acquired 2,717 shares (grant or award)
- 4 Grant or award Director acquired 1,932 shares (grant or award)
- 4 Grant or award Director acquired 1,932 shares (grant or award)
- 4 Grant or award Director acquired 4,934 shares (grant or award)
- 4 Grant or award Director acquired 1,673 shares (grant or award)
- 4 Grant or award Director acquired 2,860 shares (grant or award)
- 4 Open-market buy Chief Medical Officer bought 2,500 shares at $4.05 ($10,132)
- 4 Open-market buy President & CEO bought 4,000 shares at $3.91 ($15,647)
- 4 Open-market buy Director bought 2,500 shares at $3.98 ($9,950)
- 4 Open-market buy Controller bought 2,000 shares at $4.11 ($8,220)
- 4 Open-market buy Director bought 2,000 shares at $5.78 ($11,560)
- 4 Open-market buy Director bought 3,000 shares at $6.23 ($18,692)
- 4 Open-market sale Director sold 69,401 shares at $6.10 ($423,506)
- 4 Grant or award President & CEO acquired 430 shares (grant or award)
- 4 Grant or award Chief Medical Officer acquired 1,358 shares (grant or award)
- 4 Grant or award Controller acquired 1,678 shares (grant or award)
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
Page 11 of 37 · 739 filings